News – Page 853 – Endpoints News

SIGN UP

One less rival for Immunovant, as Alexion abandons FcRn inhibitor

6 years ago

FDA monitoring 20 drugs at risk of shortage due to coronavirus

6 years ago

Clinical trial sponsors have to disclose decade’s worth of unreleased data, federal judge rules

6 years ago

Microbiome Q&A: New study maps the vagina's 'optimal microbiota' — and its implications for biopharma

6 years ago

Tying basic science to spinouts, Dana-Farber debuts sister funds totaling $126M with MPM Capital

6 years ago

Takeda swoops in to buy little biotech partner and its celiac drug poised to 'change standard of care'

6 years ago

Theft victim or data bully? IQVIA exchanges blows with small rival it says destroyed evidence in legal fight

6 years ago

In final report, ICER appears to have a change of heart on new acute migraine therapies

6 years ago

Biogen touts new evidence from the gene therapy company it wagered $800M on

6 years ago

IDO-derived cancer vaccine scores in combo trial with Keytruda; Vir teams up with WuXi on coronavirus antibodies

6 years ago

FDA launches searchable Purple Book

6 years ago

Bicycle Therapeutics takes Roche's Genentech on an up to $2B immuno-oncology ride

6 years ago

When drug value assessment meets real-world evidence: ICER enlists Aetion in pricing evaluation

6 years ago

First US Covid-19 trials set to get underway in Nebraska and Washington, backed by NIH

6 years ago

Mallinckrodt, once the nation’s largest oxycodone producer, announces tentative $1.6B settlement

6 years ago

NIH-partnered Moderna ships off its PhI-ready coronavirus vaccine candidate to a sea of uncertainty

6 years ago

Novartis' plans to wrestle Eylea market share take a hit as Beovu is linked to safety concerns

6 years ago

SoftBank's newest, $165M biotech investment looks for infectious traces in the blood

6 years ago

Eli Lilly scores expanded MACE label for Trulicity; Gilead's CAR-T Yescarta gets in China review line

6 years ago

FDA grants ‘breakthrough’ status to antibiotic alternative as ContraFect rushes to join fight against superbug

6 years ago

NGM Bio takes leap forward in crowded NASH field

6 years ago

Harvard joins coronavirus fight with $115M and a high-profile Chinese partner

6 years ago

Novartis gets a boost in blockbuster multiple sclerosis race with Roche

6 years ago

Sanofi outlines big API plans as coronavirus outbreak reportedly threatens shortage of 150 drugs

6 years ago

First page Previous page 850 851 852853854 855 856 Next page Last page